+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Prostate Cancer Drugs Market Research Reports

Prostate Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
Global Prostate Cancer Therapeutics Market - Product Thumbnail Image

Global Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Prostate Cancer: Update Bulletin - Product Thumbnail Image

Prostate Cancer: Update Bulletin

  • Newsletter
  • March 2024
  • Global
From
From
Capecitabine Global Market Report 2024 - Product Thumbnail Image

Capecitabine Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Drugs For Benign Prostatic hypertrophy Global Market Report 2024 - Product Thumbnail Image

Drugs For Benign Prostatic hypertrophy Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
From
From
Prostate Cancer Diagnostics Global Market Report 2024 - Product Thumbnail Image

Prostate Cancer Diagnostics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Loading Indicator

The Prostate Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat prostate cancer. Prostate cancer is the most common cancer in men, and the drugs used to treat it can vary depending on the stage and severity of the disease. Common treatments include hormone therapy, chemotherapy, and radiation therapy. The Prostate Cancer Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Astellas Pharma, Bayer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly researching and developing new drugs to treat prostate cancer, as well as improving existing treatments. Show Less Read more